603259 药明康德
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)5.67527.68516.61518.89020.718
总资产报酬率 ROA (%)4.41920.87912.27413.88714.712
投入资产回报率 ROIC (%)4.97024.12614.38916.07417.209

边际利润分析
销售毛利率 (%)50.40347.63941.47941.17937.296
营业利润率 (%)45.15152.64429.51029.43027.067
息税前利润/营业总收入 (%)45.20853.46827.40228.49226.351
净利润/营业总收入 (%)37.55742.53124.38224.04622.621

收益指标分析
经营活动净收益/利润总额(%)89.21168.217103.11498.31289.975
价值变动净收益/利润总额(%)11.13035.3506.8561.6579.022
营业外收支净额/利润总额(%)-0.137-0.100-0.350-0.341-0.318

偿债能力分析
流动比率 (X)3.4223.2062.3842.0621.655
速动比率 (X)2.8992.7392.0521.7411.264
资产负债率 (%)21.08022.18126.44324.64027.460
带息债务/全部投入资本 (%)10.33210.65810.0899.43711.859
股东权益/带息债务 (%)849.896819.592861.022914.681705.652
股东权益/负债合计 (%)371.957348.496276.046303.673262.277
利息保障倍数 (X)382.91361.037-13.669-33.994-41.822

营运能力分析
应收账款周转天数 (天)54.14760.24772.71861.90648.447
存货周转天数 (天)138.324108.84879.44878.92884.420